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mesangioproliferative glomerulonephritis model, suggestingCloning of rodent megsin revealed its up-regulation in mesangio-
that megsin may participate in the process of glomerulosclerosisproliferative nephritis.
by modulating extracellular matrix deposition or cell survival.Background. We recently cloned a new human mesangium-
predominant gene, megsin. Megsin is a novel member of the
serine protease inhibitor (serpin) superfamily. To elucidate
functional roles of this gene, we cloned megsin in rodents and Mesangial cells play an important role in maintaininginvestigated its role in a rat nephritis model.
a structure and function of the glomerulus and in theMethods. Megsin homologues were cloned from cultured
pathogenesis of glomerular diseases. Severe mesangialrat and mouse mesangial cDNAs utilizing polymerase chain
reaction (PCR) with degenerative primers. Expression of meg- injury has been shown to be associated with a variety of
sin in three different types of resident glomerular cells was human glomerular diseases, including IgA nephropathy
investigated by PCR. Levels of megsin mRNA expression at and diabetic nephropathy, two common causes of end-various time points in the anti-Thy1 rat nephritis model were
stage renal diseases. The most common microscopic le-studied by semiquantitative PCR and Northern blotting analy-
sions associated with IgA nephropathy are mesangial hyp-sis. In order to investigate megsin protein expression in anti-
Thy1 nephritis rats, we raised antibody against rat megsin- ercellularity and expansion of the mesangial matrix [1].
specific synthetic peptide, with which immunohistochemical Recurrent mesangiolysis is believed to generate Kimmel-
studies were performed. stiel-Wilson nodules of diabetic glomeruli [2]. Identifica-Results. Rat and mouse megsins were composed of 380
tion and characterization of mesangium-specific genes areamino acids, which revealed 75.3 and 73.9% identity, respec-
therefore essential to understanding the pathogenesis oftively, with human megsin at the amino acid level. Characteris-
tic features as an inhibitory serpin were conserved in both glomerular diseases. For this purpose, we successfully
rat and megsin megsins. PCR analysis revealed expression of cloned a new human mesangium-predominant gene, meg-
megsin in cultured mesangial cells but not in glomerular epithe- sin, utilizing a rapid large-scale DNA sequencing andlial or endothelial cells. In anti-Thy1 nephritis rats, semiquanti-
computerized data-processing approach [3]. This meth-tative PCR and Northern blotting showed that expression of
odology was also employed by Takenaka et al to identifymegsin mRNA was up-regulated in glomeruli at day 8. Immu-
nohistochemical studies demonstrated the prominent accumu- tubule-specific genes [4, 5].
lation of megsin in glomeruli at the same time point. Megsin The megsin gene coded for a novel 380 amino acid
was mainly localized in mesangial area. The megsin expression protein, which belonged to the serine protease inhibitorlevel returned to the basal level at day 28.
(serpin) superfamily with the characteristic amino acidConclusion. Sequences of megsin were well conserved among
sequence as a functional serpin in the reactive site loopdifferent species. Rat megsin was also predominantly expressed
in mesangial cells. Expression of megsin was up-regulated at [6]. In situ hybridization studies in human biopsy speci-
the peak of hypercellularity and matrix accumulation in the mens revealed predominant expression of megsin mRNA
in the mesangium of both normal and pathological glo-
meruli in vivo. Our further quantitative analyses demon-Key words: mesangial cells, serpin, glomerulonephritis, anti-Thy 1 ne-
strated that the megsin expression was increased withphritis, glomerulosclerosis, mesangial hypercellularity, extracellular
matrix, cell survival. the degree of mesangial proliferation in the expanded
mesangium of glomeruli from patients with IgA ne-Received for publication March 2, 2000
phropathy [6]. Up-regulation of megsin mRNA expres-and in revised form February 27, 2001
Accepted for publication March 7, 2001 sion was also observed in mesangial cells of nonsclerotic
glomeruli from patients with diabetic nephropathy [7]. 2001 by the International Society of Nephrology
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To elucidate the biological roles of megsin in vivo, we Gene, Tokyo, Japan) and oligotex-dT30 (Daiichi Ka-
gaku Yakuhin, Tokyo, Japan), which was reverse tran-need to perform functional studies utilizing experimental
animals, and cloning of the rodent homologues of this scribed with SuperScript II (GIBCO BRL) and was used
as a template. Templates were amplified in a DNA Ther-gene is mandatory. In the present study, we cloned rat
and mouse megsins and studied megsin expression pro- mal Cycler (Perkin Elmer Japan, Chiba, Japan) for 35
cycles. Each cycle consisted of incubation for denatur-files in a model of mesangioproliferative glomerulone-
phritis. ation at 94C for 45 seconds, annealing at 50C for 45
seconds, and extension at 72C for two minutes. The
PCR products close to an expected size (576 bp) were
METHODS
cloned into the pCRII vector (Clontech, Palo Alto, CA,
Culture and characterization of rat and mouse USA), and DNA sequences were determined by dideoxy
mesangial cells chain termination reaction using a DNA autosequencer.
From a partial clone of rat megsin, 27.2c, gene-specificGlomeruli were isolated by differential sievings from
normal rat or mouse renal cortices as reported previously primers were designed, and degenerative PCR was per-
formed again to obtain the 5 region of the partial rat[8]. Isolated glomeruli were resuspended in Dulbecco’s
modified essential medium (DMEM; GIBCO BRL, Gaith- megsin. A degenerate primer ATG GCN TCN GCN
GCN GCN GCN AAY GC (Y is T or C) correspondedersburg, MD, USA) containing 10% fetal bovine serum
and antibiotics (50 U/mL penicillin and 50 g/mL strep- to the N-terminus of human-megsin coding sequences
and was named RM-CtermC1. PCR was performed withtomycin) and were incubated in a 5% CO2 incubator.
Mesangial cells were characterized by a series of crite- a rat megsin-specific reverse primer RM-MR-A2 (CGA
CCT CCA GAG GCA ATT CCA GAG AGA TCAria [9]: typical morphologic features; tolerance to trypsin,
puromycin and D-valine; and the positive immunostain- GCC CTG G) for 45 cycles, with each cycle consisting
of an incubation for denaturation at 94C for 45 seconds,ing for -smooth muscle actin and absence of staining
for von Willebrand factor, a marker for endothelial cells, annealing at 55C for 45 seconds, and extension at 72C
for one minute. Utilizing the PCR product as a template,and cytokeratin, a marker for parietal epithelial cells.
nested PCR was performed with a combination of RM-
Culture of rat glomerular epithelial CtermC1 and another rat megsin-specific reverse primer
and endothelial cells RM-MR-A1 (GTC TTC CAA GCC TAC AGA TTT
CAA GTG GCT CCT C) for 25 cycles with each cycleCultured rat glomerular epithelial cells were generous
gifts from Dr. William G. Couser (Division of Nephrol- consisting of an incubation for denaturation at 94C for
45 seconds, annealing at 55C for 45 seconds, and exten-ogy, University of Washington, Seattle, WA, USA), and
its characterization has been described elsewhere [10]. sion at 72C for one minute. To amplify the products
further, PCR was repeated with a combination of theThe cells were maintained in K-1 medium supplemented
with 2% NuSerum (Collaborative Research, Bedford, same primers for 25 cycles, with each cycle consisting
of incubation for denaturation at 94C for 30 seconds,MA, USA) at a final concentration of 5 g/mL insulin, 5
g/mL transferrin, and 5 ng/mL selenium (Collaborative annealing at 55C for 30 seconds, and extension at 72C
for 40 seconds. The PCR products close to an expectedResearch).
Cultured rat glomerular endothelial cells were gener- size were cloned into the pGEM-T-easy vector (Pro-
mega, Madison, WI, USA), and DNA sequences wereous gifts from Dr. Stephen Adler (Renal Unit, New York
Medical College, Valhalla, NY, USA), and its character- determined.
To obtain sequences containing the initiation codonization has been reported previously [11]. They were
grown and passaged on fibronectin-coated plates in or the stop codon of megsin, we performed 5-RACE and
3-RACE with primers designed based on the sequencesRPMI1640 with 10% fetal calf serum (FCS) and 10%
NuSerum (Collaborative Research). obtained as previously mentioned utilizing Marathon
cDNA amplification kit (Clontech). For 5-RACE, two
Cloning of rat megsin cDNA gene-specific antisense primers, RM-PRO1 (GCT CAG
GGC AGT GAA GAT GCT CAG GGA AGA) andIn order to clone a rat homologue of megsin, polymer-
ase chain reaction (PCR) was performed with degenera- RM-PRO2 (CTG ACG TGC ACA GTC ACC TCG
AGC ACC), were employed. For 3-RACE, a gene-tive primers designed from human megsin cDNA. For-
ward primer GTG AAT GCT GTG TAC TTA AAG specific sense primer RM-MR-S3 (GAG GTC TCA
GAA GAA GGC ACT GAG GCA ACT GCT GCC)GCA ANT GN named FY corresponded to 172VNAV
YFKGK180. Reverse primer AAN AGR AAN GGR was used.
To obtain clones containing the open reading frameTGR TCN GC (R is A or G) named R21 corresponded
to 357ADHPFLF363. mRNA was obtained from cultured of rat megsin, two gene-specific primers designed utiliz-
ing the sequences obtained above were employed. Senserat mesangial cells at passage 14 with ISOGEN (Nippon
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primer was RM-5UTR-FS2 (CTC TAT AGG AGA program that predicts protein localization sites. Sequence
alignment and pustell matrix comparison were performedCAC TTG G), and antisense primer was 3UTR-A1
(GAA ACA AAT CAA AGC AAA C). The PCR was according to the protein-scoring matrix pam250 with
MacVector (International Biotechnologies, Inc., New Ha-performed for 35 cycles, with each cycle consisting of
incubation for denaturation at 94C for 45 seconds, an- ven, CT, USA). The Kyte-Doolittle scale [15] was em-
ployed to investigate a hydrophilicity profile with Mac-nealing at 50C for 45 seconds, and extension at 72C
for one minute 30 seconds. Vector. Secondary structure prediction was performed by
PHD (Profile fed neural network system from Heidelberg)
Cloning of mouse megsin cDNA sec according to the Rost and Sander secondary structure
prediction method [16].For cloning of a mouse homologue of megsin, PCR
with degenerative primers also were employed. The prim-
Anti-Thy1 antibodyers were designed from human and rat megsin cDNA.
The first forward primer GAA ATT GAA ARC AAR A hybridoma line producing anti-rat Thy1.1 antibody
was purchased from the European Collection of AnimalCTG ASY TTY CAG AAT (R is A or G, Y is C or T,
and S is C or G) was named MF-1 and corresponded to Cell Culture (Salisbury, UK). Purification of anti-Thy1.1
monoclonal antibody was performed as reported pre-749 to 778 bp of rat megsin cDNA. The second forward
primer CTG ASY TTY CAG AAT CTA ATG GAM viously [17]. In brief, the hybridoma cells were cultured
in RPMI-1640 medium containing 10% fetal bovine se-TGG AC was named MR-2 and corresponded to 764 to
792 bp of rat megsin cDNA (M is A or C). Reverse rum, and 1  106 cells suspended in 0.5 mL of RPMI-
1640 were inoculated into the peritoneal cavities of 10-primer GGA YTS AGG RAG TWG CTT TTC WAC
RAT RTT was named MR-4 and corresponded to 1034- week-old male Balb/c mice, which had been injected with
incomplete Freund’s adjuvant intraperitoneally seven1063 (W is A or T). Ten micrograms of total RNA were
obtained from cultured mouse mesangial cells (passage days earlier. Within two weeks after the hybridoma injec-
tion, ascites was obtained from the mice. The ascitic fluid9) with ISOGEN (Nippon Gene, Tokyo, Japan), which
was reverse transcribed with SuperScript II and was used was centrifuged to remove insoluble materials, and the
supernatant was pooled. Then, the pooled ascites wereas a template. Templates were amplified for 30 cycles
with primers of MF-1 and MF-4. Each cycle consisted dialyzed against phosphate-buffered saline (PBS), and the
IgG-rich fraction was precipitated with 50% saturatedof incubation for denaturation at 94C for one minute,
annealing at 60C for one minute, and extension at 72C ammonium sulfate. The crude antibodies were applied to
HiTrap Protein A column (Pharmacia Biotech, Tokyo,for 30 seconds. The PCR products were utilized for
nested PCR utilizing primers of MF-2 and MF-4 under Japan) to purify IgG. Purified IgG was eluted into the
elution buffer (0.1 mol/L sodium citrate, pH 5) and wasthe same conditions. The final products close to an ex-
pected size (300 bp) were cloned into the pGEM-T easy dialyzed against PBS before use.
vector, and DNA sequences were determined.
Experimental design of animal studies3-RACE was performed utilizing the Marathon cDNA
amplification kit to obtain the remaining 3-region of All animal experimentation was conducted in accor-
dance with the Guide for Animal Experimentation (Fac-mouse megsin. Two gene-specific primers, MMF3 (GAG
GTC TCA GAG GAG GGC ACT GAA GCC ACT ulty of Medicine, University of Tokyo, Tokyo, Japan).
Male Wistar rats, six weeks old, were purchased fromGCT GCC) and MMF4 (CCA GTG CAG ATC TCT
CTG GAA TTG CCT CTG GAG GTC GTC), were Charles River Japan (Yokohama, Japan), and after pre-
liminary breeding for one week, they received a 1.2 mg/kgdesigned from this partial clone of mouse megsin. The
5 region of mouse megsin was obtained by PCR with a body wt intravenous injection of IgG1 mouse mono-
clonal anti-Thy1 antibodies (OX-7) or vehicle (control).gene-specific reverse primer, MMR6, designed from the
partial sequence of mouse megsin cDNA and a degener- The protein concentration in 24-hour urine was mea-
sured using Pyrogallol Red, by means of a commercialative primer, DG-RMF1 (ATG GCY TCC CTY GCT
GCW GCR AAT GCA GAR TTT KGC), correspond- kit (Wako Pure Chemical Industry, Tokyo, Japan), and
the total amount of protein in the 24-hour urine samplesing to the 5 end of rat and human megsin coding region.
was calculated. Serum was separated by centrifugation
Analysis of the amino acid sequence from blood samples, and the blood urea nitrogen (BUN)
was measured using urease-indophenol by means of aA motif search was performed utilizing a Motif Finder
program written by Dr. Atsushi Ogiwara (Institute for commercial kit (Wako).
For semiquantitative PCR experiments, three ratsChemical Research, Kyoto University, Japan). This pro-
gram searches PROSITE [12, 13] and MotifDic [14]. To were sacrificed prior to (day 0) 2, 4, 8, 14, and 28 days
after treatment, and glomeruli isolated by a conventionalfind a signal sequence, we applied PSORT II (Dr. Kenta
Nakai, National Institute for Basic Biology, Japan), a sieving method [8] were utilized to isolate RNA. In order
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to perform Northern blotting and immunohistochemical separated in 1% agarose containing 2.2 mol/L formalde-
hyde denaturing gel, followed by capillary transfer toanalysis, the kidneys were harvested at the same time
points. Six rats were sacrificed at each time point, and nitrocellulose filter. As a probe, partial cDNA of rat
megsin from clone 27.2c was used. The membrane wasthis set of experiments was repeated twice. One kidney
was disaggregated by sieving for separating glomeruli hybridized in a Rapid Hyb solution for three hours at
65C (Amersham, Arlington Heights, IL, USA). The[8], and RNA was purified from the isolated glomeruli
using ISOGEN (Nippon Gene). The other was embed- blot was washed to a final stringency of 0.1  standard
saline citrate(SSC)/0.1% sodium dodecyl sulfate (SDC)ded in OCT (Lab-Tek Products; Miles Laboratories, Na-
perville, IL, USA) and snap frozen in acetone in liquid at 60C.
A rat multiple tissue Northern blot was purchasednitrogen for frozen sections.
from Clontech. A rat multiple tissue Northern blot con-
Semiquantitative reverse transcriptase-polymerase tains 2 g of polyA RNA from heart, brain, spleen,
chain reaction lung, liver, skeletal muscle, kidney, and testis. Hybridiza-
tion and washing were performed as described previouslyOne microgram of total RNA from cultured glomeru-
lar cells or total glomerular RNA from each rat was in this article. Consequent Northern blotting analysis of
the same membranes with a -actin probe after dehy-utilized to synthesize cDNA with SuperScript II (GIBCO
BRL) according to the manufacturer’s protocol. One mi- bridization confirmed loading of equal amounts of RNA
in each lane (data not shown).croliter of the reverse transcription (RT) reaction mixture
was utilized for the subsequent semiquantitative PCR.
Renal histologyAs primers for rat megsin, a forward primer, rat meg-
sin S27 (AGA ATT TGG CTT CGA CTT ATT CAG Methyl Carnoy’s fixed tissue was processed, and 4
m sections were stained with the periodic acid-SchiffAGA GAT GG), corresponding to 34 to 65 bp, and a
reverse primer, rat megsin AS506 (ATG ACA GCT GAT reagent and counterstained with hematoxylin. The num-
bers of glomerular cells and proliferating cells presentGAG CTG AGG CTG CTG TCC CCC), corresponding
to 481 to 513 bp, were employed. The PCR was per- per glomerular cross-section were counted in a blinded
fashion. Thirty randomly selected glomeruli were exam-formed with each cycle consisting of incubation for dena-
turation at 94C for one minute, annealing at 60C for ined per rat, and the average number per glomerulus was
calculated. Glomerular cross-sections containing only aone minute, and extension at 72C for one minute. For
-actin, we designed a forward primer, rat -actin forward minor portion of the glomerular tuft (20 discrete capil-
lary segments per cross-section) were not utilized.(GTG TGA TGG TGG GTA TGG GTC AGA AGG
ACT), corresponding to 1455 to 1484 bp, and a reverse Glomerular cell proliferation was assessed by staining
with PC10, an antibody to the proliferating cell nuclearprimer, rat -actin reverse (ATG GCA TGA GGG
AGC GCG TAA CCC TCA TAG), corresponding to antigen (PCNA), as described later in this article. Mesan-
gial cell activation was assessed by staining with 1A4, an2318 to 2288. Amplification products were visualized by
agarose gel electrophoresis. The amplification of -actin antibody to -smooth muscle actin, as described later in
this article. For the evaluation of the staining for -smoothmRNA served as a control for the integrity of cDNA and
allowed for the subsequent allocation of approximately muscle actin, each glomerulus was graded semiquantita-
tively [18]: 0 	 no staining; 1 	 mesangial staining withequivalent amounts of cDNA for each megsin amplifica-
tion reaction. -Actin and megsin mRNA amplification 1 to 25% of the glomerular tuft; 2 	 25 to 50% of the
glomerular tuft demonstrating positive staining; 3 	 50reactions were tested further to ensure that the number
of cycles used remained outside the reaction plateau, to 75% of the glomerular tuft showing positive staining;
and 4 	 
75% of the glomerular tuft staining strongly.that is, within the increasing range of amplification. This
test consisted of a visual sampling of the progress of each
Anti-rat megsin antibodyamplification reaction between 25 and 40 cycles. Thus,
the assay for megsin mRNA was semiquantitative because The peptide corresponding to particular region of
megsin (P2: amino acid residues from 341 to 354, ESNIthe amount of cDNA used in each amplification was nor-
malized to yield comparable signal upon -actin mRNA VEKLLPESTV) with a cysteine residue at their N-termi-
nus was synthesized on an automatic synthesizer modeland because reaction parameters were selected for detec-
tion outside the reaction plateau. Negative controls for 432A (Perkin Elmer, Foster City, CA, USA). It was
purified by reverse-phase high performance liquid chro-RT-PCR included parallel amplification reactions lack-
ing reverse transcriptase or lacking cDNA template. matography and was lypophilized and used as an immu-
nogen to raise rabbit anti-rat megsin antibodies.
Northern blot analysis Synthetic megsin peptide was conjugated with hemo-
cyanin (KLH; Calbiochem-Novabiochem, La Jolla, CA,Isolated RNA from rats at each time point was com-
bined, and 20 g of total RNA were electrophoretically USA). In brief, KLH suspended in 0.05 mol/L sodium
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phosphate buffer (pH 7.2) was reacted with m-maleimi- Immunohistochemistry
dobenzoyl-N-hydorosuccinimide ester (MBS) dissolved Rat renal tissue specimens embedded in the Tissue-
in dimethylformamide and stirred for 30 minutes at room Tek O.C.T. compound (Miles Inc., Elkhart, IN, USA)
temperature. The reaction mixture was dialyzed against were sectioned at 4 m and fixed in 4% paraformalde-
0.05 mol/L sodium phosphate buffer (pH 6.0, KLH-MB) hyde in PBS. After washing with PBS, the sections were
and was incubated with the peptide suspended in distilled dehydrated through graded ethanol, incubated in metha-
water. Half volume of 0.2 mol/L disodium hydrogen nol with 0.3% H2O2 for 20 minutes at room temperature
phosphate was added into the KLH-MB, which was to block endogenous peroxidase, and washed three times
stirred for three hours at room temperature, dialyzed with PBS containing 0.25% Tween 20. After washing,
against PBS, and finally lyophilized. the sections were preincubated with the blocking buffer
(Block Ace; Snow Bland, Tokyo, Japan) for 60 minutesThis synthetic peptide conjugated with KLH was used
at room temperature, followed by the incubation withto immunize rabbits with complete Freund’s adjuvant
rabbit anti-rat megsin IgG or preimmune serum IgG from(DIFCO Laboratories, Sparks, MD, USA) and subse-
immunized rabbit at 4C overnight. The sections werequently with incomplete Freund’s adjuvant (DIFCO
then incubated with 1:50 diluted peroxidase-conjugatedLaboratories) every two to three weeks for five times.
swine anti-rabbit antibody (Dako, Glostrup, Denmark)IgG from immune serum was purified with a protein A
for 30 minutes at room temperature and developed withaffinity column (Pharmacia Biotech, Uppsala, Sweden).
33-diaminobenzidine tetrahydrochloride solution con-Preimmune sera had also been obtained from these im-
taining 0.03% H2O2, followed by the counterstaining withmunized rabbits, and IgG was purified.
hematoxylin. Competitive experiments to confirm the
specificity of immunostaining were performed with anti-Immunoblot analysis
megsin antibody, which had been incubated with an ex-Recombinant megsins were produced in both Esche-
cess of synthetic rat megsin peptide P2.richia coli and Chinese hamster ovary (CHO) cells (Inagi
An indirect immunoperoxidase method was used onR., Miyata T., Nangaku M., Kurokawa K., manuscript
methyl Carnoy’s fixed tissues as previously describedin preparation). In brief, fusion human megsin protein with
[19] to identify following antigens to investigate temporalmaltose binding protein (MBP-megsin) was expressed in
profiles of their expression in anti-Thy1 nephritis: theE. coli (DH5) utilizing a maltose-binding fusion protein
PCNA with mouse monoclonal antibody PC10 (Dakovector, pMALc2 (New England Biolabs, Beverly, MA,
A/S) and-smooth muscle actin with murine monoclonal
USA). Expression of human megsin recombinant pro-
antibody 1A4 (Sigma, St. Louis, MO, USA).
tein in CHO cells was performed utilizing pREP9 (In-
vitrogen, Carlsbad, CA, USA), a mammalian expression Immunofluorescence studies
vector. To perform double staining with anti-megsin antibody
The purified recombinant megsins were separated by and anti–-smooth muscle actin antibody, we used fro-
sodium dodecyl sulfate-polyacrylamide gel electropho- zen renal tissues sectioned at 4 m and fixed in 4%
resis (SDS-PAGE) using a 10% acrylamide gel and elec- paraformaldehyde in PBS as described previously in this
trophoretically transferred to a polyvinylidene difluoride article. For detection of -smooth muscle actin, FITC-
membrane (Bio-Rad Laboratories, Hercules, CA, USA). labeled 1A4 monoclonal antibody (Sigma) was utilized.
The membrane was blocked with PBS containing 0.05% To detect rat megsin, Texas Red-labeled swine anti-rab-
Tween 20 and 2% bovine serum albumin overnight at bit IgG (Dako) was employed at 1:200 dilution.
4C, incubated with rabbit anti-megsin IgG or preimmune
serum IgG from immunized rabbits (10 g/mL each) for Statistical analysis
one hour at room temperature, and washed with PBS Values were expressed as mean  SD and analyzed
containing 0.05% Tween 20 (PBS-Tween). The mem- by the Student t test. Values were considered significant
brane was then incubated with 1:5000 diluted alkaline- if P was 0.05.
phosphatase conjugated goat anti-rabbit IgG (Cappel,
Durham, NC, USA) for one hour at room temperature,
RESULTSfollowed by washing and development with a p-nitro
Cloning of rodent megsinsblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-
phosphate solution (Bio-Rad Laboratories). To clone a rat homologue of megsin, we performed
Competitive experiments to confirm the specificity of PCR with cDNA from cultured rat mesangial cells utiliz-
immunostaining were performed with anti-megsin anti- ing degenerative primers designed from human megsin
body, which had been incubated with an excess of syn- cDNA. One clone, named 27.2c, contained sequences
that showed high homology with human megsin cDNA.thetic rat megsin peptide P2.
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Fig. 1. Amino acid sequences deduced from
rat and mouse megsin cDNAs. The sequenc-
ing of rat (A) and mouse (B) cDNAs revealed
an open reading frame of 1140 nucleotides
coding for a 380 amino acid polypeptides for
each. The reactive site loops are enclosed by
open boxes. Two putative hydrophobic re-
gions are indicated by single underlines. Dou-
ble underlines indicate the serpin signatures.
Five potential N-glycosylation sites are indi-
cated by asterisks. The accession numbers for
the nucleotide sequence of rat and mouse
megsin are AF105329 and AF105328, respec-
tively (DNA Data Bank of Japan, European
Molecular Biology Laboratory, and GenBank).
Utilizing degenerative PCRs, 5-RACE, and 3-RACE assess alterations of megsin expression after mesangial
with primers specific to this clone, four independent injury. Anti-Thy1–treated rats showed significant eleva-
clones of 1229 bp were obtained. The nucleotide se- tions of urinary protein excretion compared with control
quencing analysis of rat megsin revealed an open reading animals at day 8 (272  13.1 vs. 86.3  13.6 mg/kg body
frame of 1140 nucleotides coding for a predicted protein wt, P  0.05). The levels of proteinuria and histology of
of 380 amino acids with five potential N-glycosylation the kidneys of anti-Thy1–treated animals returned to
sites (the deduced molecular weight, 43 kD; Fig. 1A). normal values at day 28 (66.8  6.45 mg/kg body wt).
The sequence around the initiation codon (AAAATGG) Detailed histological analysis demonstrated a decrease
of rat megsin was consistent with Kozak’s consensus in glomerular cellularity due to mesangiolysis at day 2
sequence (A/GCCATGG). Stop codons in all three (59.3  1.9 cells per glomerulus vs. 78.3  2.0 at day 0),
frames were located upstream of the initiation codon. followed by a subsequent increase in total cellularity at
Amino acid sequences of rat megsin showed 75.3% iden-
day 4 (69.5  3.2) and day 8 (92.6  2.9). The number
tity with human megsin (Fig. 2A).
of glomerular cells returned to the basal level at day 28We also cloned a megsin homologue from cultured
(76.5  3.4). Expression of -smooth muscle actin inmouse mesangial cells. This cDNA also contained the
glomeruli was first noted four days after injection of OX-71140 bp coding region (Fig. 1B). Amino acid sequences
(1.6  0.2) and was increased at day 8 (3.4  0.2). Aof mouse megsin showed 73.9% identity with human
low expression level of -smooth muscle actin was stillmegsin (Fig. 2B) and 91.3% identity with rat megsin
observed in glomeruli at day 28 (1.3  0.2). Glomerular(Fig. 2C).
cell proliferation was increased at day 2 (7.7 3.3 PCNA-
Rat megsin was predominantly expressed by positive cells per glomerulus vs. 0.9 0.2 at day 0), peaked
glomerular mesangial cells at day 4 (18.6  2.2), remained high at day 8 (14.3 
As human megsin was a gene predominantly ex- 2.0), and returned to normal at day 28 (1.4  0.4).
pressed by glomerular mesangial cells, we investigated
Megsin mRNA levels were increased at day 8 in anti-expression of megsin by Northern blot analysis in a vari-
ety of rat organs. However, no band corresponding to Thy1 nephritis rats
megsin mRNA could be detected (data not shown). This To examine megsin expression at the mRNA level in
was not surprising because we observed the same find- these rats, RNA was extracted from the glomeruli and
ings in human tissues [6]. Therefore, we investigated semiquantitative PCR analysis was performed. The am-
the expression of megsin mRNA in cultured cells. PCR
plification of -actin mRNA served as a control for the
analysis demonstrated expression of megsin in cultured
integrity of cDNA and allowed for the subsequent alloca-mesangial cells, but not in glomerular epithelial or endo-
tion of approximately equivalent amounts of cDNA forthelial cells (Fig. 3A), suggesting that rat megsin is also
each amplification reaction. Different cycles of amplifi-predominantly expressed in mesangial cells.
cation reactions were tested to ensure that the number
Anti-Thy1 nephritis model of rats was employed to of cycles used remained outside the reaction plateau,
study megsin expression in damaged glomeruli that is, within the increasing range of amplification. When
PCR was performed for 33 cycles, up-regulation of meg-Anti-Thy1 nephritis, a representative model of mesan-
gioproliferative glomerulonephritis in rats, was used to sin was clearly demonstrated at day 8 (Fig. 3B). Three
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tive photograph of the Northern blotting experiments is
shown in Figure 4, demonstrating the up-regulation of
megsin expression at day 8.
Immunohistochemical analysis showed up-regulation
of megsin in anti-Thy1 nephritis glomeruli
The protein distribution does not necessarily colocal-
ize with that of its mRNA. Furthermore, megsin is a
member of the serpin superfamily and may therefore
work as a secretory factor, although its target is still
unknown. To elucidate its biological function in vivo, it
is essential to examine expression and localization of
megsin protein in the kidney. We therefore raised poly-
clonal antibody against synthetic peptide of rat megsin
and studied the localization of megsin protein using im-
munohistochemical methods. The antigenic synthetic
peptide corresponded to 341 to 353 amino acids of rat
megsin, which are conserved between human and ro-
dents but do not share sequence homology with the other
members of the serpin superfamily.
Our Western blot analysis demonstrated the specificity
of this antibody (Fig. 5). The anti-megsin antibody re-
acted with MBP-megsin (lane 1), CHO-megsin (lane 2),
but not with MBP (lane 3) or KLH (data not shown).
The binding of antibody to recombinant megsins did
not reflect nonspecific binding because immunoreactivity
was completely inhibited in the presence of an excess
of synthetic megsin peptide (lane 4) and because no
immunoreaction was observed with preimmune rabbit
IgG from the immunized rabbit (lane 5).
Immunohistochemical analysis with this antibody lo-
calized accumulation of megsin protein exclusively in rat
glomeruli (Fig. 6), whereas other organs, including liver,
spleen, and lung were negative (data not shown). Deposi-
tion of megsin was observed mainly in mesangial areas.
At day 0 prior to the induction of the disease, megsin-
positive cells were sparse in glomeruli, as in the control
animals at any time points (data not shown). Staining of
megsin was even less at day 2, probably due to ongoing
mesangiolysis. Accumulation of megsin was slightly up-
regulated at day 4 and was most prominent at day 8. As
megsin deposition increased, some glomerular epithelialFig. 2. Comparison of the amino acid sequences of megsin among
different species. Comparisons of the protein sequences between human cells also showed positive staining. Increased deposition
and rat (A), human and mouse (B), or rat and mouse (C) megsins are
of megsin was still clear at day 14, but it returned toshown. Matching regions are shown as diagonal lines. These sequences
were aligned according to the protein scoring matrix pam250 with win- normal at day 28. Staining was negative when preimmune
dow size 8, minimum % score 60, and hash value 2. serum was used or when the antibody was preincubated
with an excess of megsin peptide (Fig. 6).
To investigate the association of megsin with activa-
tion of mesangial cells further, we performed doubleindependent RT-PCR analyses showed essentially the
staining of tissues from animals with Thy1 nephritis atsame results.
day 8 with antibodies to megsin and -smooth muscleUp-regulation of megsin RNA expression at this time
actin, a marker of mesangial cell activation. Megsin waspoint was further confirmed by Northern blot analysis in
predominantly localized in the -smooth muscle actin-two separate experimental animal groups. A long-time
exposure revealed a faint band of megsin. A representa- positive area (Fig. 7).
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Fig. 3. Semiquantitative polymerase chain
reaction (PCR) demonstrated mesangium-
predominant expression and up-regulation of
megsin at day 8 of the anti-Thy1 nephritis
model in rats. (A) PCR analysis demonstrated
expression of megsin in cultured rat mesangial
cells (MCs), whereas no expression was de-
tected in cultured glomerular epithelial (GEC)
or endothelial (GEN) cells. (B) One micro-
gram of total RNA was utilized to synthesize
cDNA, which was used for the subsequent
semiquantitative PCR. When PCR was per-
formed for 33 cycles, up-regulation of megsin
was clearly demonstrated. Each lane corre-
sponds to a different animal and three animals
were studied at each time point. The number
of days after anti-Thy 1 antibody treatment is
shown.
DISCUSSION served both in rat and mouse. The stretch of -sheet im-
mediately preceding the NH2-terminal side of the reactiveWe cloned rat and mouse homologues of the new
site loop is a prerequisite for proteinase inhibition andhuman mesangium-predominant gene, megsin, utilizing
limits the sizes and charges of amino acids in the hingePCR techniques.
region to achieve appropriate conformational change.The structural evidence as an inhibitory serpin pro-
This -sheet stretch was also conserved both in rat andposed for human megsin [6] was conserved in rodent meg-
mouse megsins.sin. The Peven residues of the megsin reactive site loop
The reactive center of inhibitory serpins has been lo-were uncharged, small, and nonpolar, which is a charac-
calized to an exposed loop of amino acids (reactive siteteristic feature of the inhibitory serpins. Inhibitory ser-
loop) that may resemble a structure within the naturalpins are known to have the sequence of Ala-Ala (Thr)-
substrate of the serpin’s target protease [21–23]. SerpinsAla-Ala at the NH2-terminal region of the reactive site
inactivate proteinases by utilizing a mobile reactive siteloop (P12 to P9), called the hinge region. P12 to P9 of the
loop to bait and trap their target serine proteinases. Somereactive site loop of megsin were Ala-Thr-Ala-Ala. The
studies have shown that residues flanking the putativeP17-P8 sequence of human megsin (Glu-Gly-Thr-Glu-
scissile bonds within the reactive site loop (P1 and P1)Ala-Thr-Ala-Ala-Thr), which was consistent with the
are important in determining the substrate specificityconsensus sequence among inhibitory serpins (Glu-Gly-
Thr-Glu-Ala-Ala-Ala-Ala-Thr) [20], was completely con- [24–26], while the residues other than P1 played only a
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that can be either secreted or cytoplasmic due to these
noncleavable internal signal sequences in  helix A and
B, as shown in some other serpins [29–31].
Summarizing all of these data of megsin homologues,
their characteristics as a functional serpin were well con-
served among different species. This strongly suggests
that megsin plays an important biological role in vivo.
Our studies utilizing cultured glomerular cells demon-
strated predominant expression of rat megsin in mesan-
gial cells, which was consistent with the cell type-specific
expression pattern of human megsin [6]. While our
Northern blot analysis did not detect megsin transcripts
in rat kidney samples, it was not surprising as the same
observation was made in human megsin [6]. We specu-
late that this discrepancy is due to the small number of
mesangial cells in the kidney, which is also composed of
a variety of other cells including endothelial cells and
epithelial cells. Furthermore, we believe that expression
of megsin in cultured mesangial cells, which are known
to acquire activated phenotypes, is increased.
Encouraged by these observations, we employed an
animal model of mesangial injury and proliferation, anti-
Thy1 nephritis model in rats, and investigated the expres-
sion pattern of rat megsin. Anti-Thy1 antibody-induced
nephritis is a well-established model of experimental
mesangoproliferative glomerulonephritis because selec-
tive damage of mesangial cell allows the study of mesan-
gial function and pathophysiology [reviewed in 32]. The
mesangiolysis is followed by mesangial cell proliferation
and excessive production of extracellular matrix and thus
resembles human proliferative glomerulonephritis. The
glomerular lesions subside in approximately one month.
Semiquantitative PCR and Northern blotting showed the
up-regulation of megsin mRNA expression in glomeruli
at day 8, the peak of glomerular hypercellularity and
Fig. 4. Northern blotting analysis revealed an up-regulation of megsin mesangial matrix accumulation in this model.
mRNA at day 8 of the anti-Thy1 nephritis model in rats. Twenty micro- In order to study megsin at the protein level, we raisedgrams of total RNA were electrophoretically separated and transferred
polyclonal antibodies against synthetic peptides of ratto a nitrocellulose filter. Megsin RNA was up-regulated at day 8. Hori-
zontal bars correspond to the sizes of 28S and 18S ribosomal RNA (5.1 megsin and performed an immunohistochemical analysis.
and 1.9 kb, respectively). Deposition of megsin protein, which localized mainly in
mesangial area, was also most prominent at day 8. Our
immunohistochemical studies showed prominent, but not
exclusive, localization of megsin in the mesangial area.minor functional role in other proteins [27, 28]. The
residues at P1 and P1 of human and mouse megsin are Furthermore, some glomerular epithelial cells also showed
positive staining when deposition of megsin was increasedLys-Gln. Those of rat megsin are Lys-Leu. Serpins such
as the Kunitz-type bovine basic protease inhibitor are at day 8 of anti-Thy1 nephritis. This was not completely
surprising as megsin is supposed to be a secretory mole-known to have Lys at P1 and inhibit trypsin strongly.
Conservation of Lys at P1 of megsin among different spe- cule. We do not know whether megsin deposition in glo-
merular epithelial cells derived from mesangial cells orcies suggests that the target serine protease of megsin
might be a Lys-cleaving protease. whether megsin was produced in epithelial cells in situ.
However, our PCR analysis of cultured glomerular cellsThe hydrophilicity profile revealed two hydrophobic
regions in  helix A (amino acids 1 to 16) and B (amino demonstrated expression of megsin in cultured mesan-
gial cells, but not in glomerular epithelial or endothelialacids 27 to 44) of rat and mouse megsin. The absence
of an apparent NH2-terminal signal peptide sequence in cells, suggesting that megsin deposition in other areas
might originate from mesangial cells. Double stainingmegsin suggests that megsin exists as a dualistic molecule
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Fig. 5. Characterization of anti-rat megsin an-
tibody. Recombinant megsins or control pro-
tein (2 g each) were resolved by 10% sodium
dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), followed by immuno-
blotting using anti-rat megsin antibody. Lane
1, E. coli-derived MBP-megsin fusion protein;
lane 2, CHO cells-derived c-myc-histidine-
tagged megsin; lane 3, MBP; lane 4, anti-rat
megsin antibody, which had been preincu-
bated with an excess of synthetic rat megsin
peptide P2; lane 5, preimmune rabbit IgG. The
position of each recombinant protein is indi-
cated by an arrowhead.
was also performed with megsin and -smooth muscle gial cells can express a variety of extracellular matrices
actin, a marker of activated mesangial cells. Although and proteinases [35, 36], depending on their state of activa-
most megsin-expressing cells were-smooth muscle actin– tion. Recent studies demonstrated that transgenic mice
positive, these two molecules did not necessarily coexist. that overexpress the plasminogen activator inhibitor type
Megsin expression in mesangial cells may be regulated 1 (PAI-1) showed more marked lung fibrosis in response
by some other factors in addition to mesangial activation. to bleomycin than wild-type mice, whereas PAI-1 knock-
To determine the exact localization of megsin, immu- out mice were relatively protected [37], emphasizing the
noelectron microscopic studies are required. Although role of serpin in extracellular matrix accumulation. Up-
we intensively tried immunoelectron microscopic analy- regulation of megsin may regulate the activities of pro-
sis utilizing the currently available antibodies against teinases secreted during mesangial injury and activation.
megsin, all attempts were unsuccessful. In our immuno- Anatomical location of mesangium suggests another
histochemical studies these antibodies stained only fro- possible role of megsin on adjacent glomerular endothe-
zen sections, and we assume that antigenic epitopes rec- lial cells. Mesangial cells extend around the capillary
ognized by these antibodies may lose their antigenicity lumen and insinuate themselves between the basement
during the fixation processes for electron microscopy. membrane and the overlying endothelium. Some serpins
Thus, we are now trying to raise new megsin antibodies
are among the most potent natural inhibitors of angio-
that make immunoelectron microscopic analysis feasible.
genesis [38–40], and the complex relationship betweenOur studies described here are descriptive in nature,
mesangial cells and endothelial cells raises a possibilityand functional studies are necessary to clarify the patho-
that megsin accumulating in mesangial area may exhibitphysiological roles of megsin in glomerular disorders.
some effects on adjacent endothelium. With emphasizedUp-regulation of megsin may be just an epiphenomenon
roles of endothelial damage in the initiation and propa-of mesangial injury and/or activation [33, 34]. However,
gation of glomerulosclerosis and end-stage renal dys-its structural characteristics as a functional serpin suggest
function [41–45], the possible roles of megsin on glomer-several roles of megsin in the pathophysiology of dam-
ular endothelial cells also should be pursued.aged glomeruli, allowing us to make fascinating specula-
In conclusion, we cloned homologues of megsins intions on the potential functions of megsin. Accumulation
rodents. Both rat and mouse megsins conserved charac-of extracellular matrix as a consequence of their in-
teristic structural features of functional serpin. Rat meg-creased synthesis and relative inhibition of degradation
sin was predominantly expressed in mesangial cells. Meg-by proteases leads to glomerulosclerosis. The turnover
sin was up-regulated in the anti-Thy1 nephritis model ofand modeling of mesangial extracellular matrix requires
mesangioproliferative glomerulonephritis when hyper-the secretion and extracellular action of proteinases, and
cellularity and excessive production of extracellular ma-the enzymatic activity of a protease is regulated by a
balance among proteinases and their inhibitors. Mesan- trix were at their peaks. Megsin may participate in the
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Fig. 6. Immunohistochemical analysis of anti-Thy1 nephritis rats showed prominent deposition of megsin at day 8. At day 0, megsin-positive cells
were sparse in glomeruli. Staining of megsin was barely detectable at day 2. Accumulation of megsin was slightly up-regulated at day 4. Mesangial
area at day 8 was intensely positive for megsin staining. Increased deposition of megsin was still prominent at day 14, but returned to the basal
level at day 28 (200).
Fig. 7. Double staining of megsin (A) and -smooth muscle actin (B) alone or in combination (C). Immunofluorescence studies, utilizing anti-
rat megsin (red) and anti--smooth muscle actin antibody (green), demonstrated that megsin was predominantly localized in an -smooth muscle
actin-positive area (yellow; 200).
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